| CAT. No. | MRL-D45001 |
| CAS. No. | 211915-06-9 |
| Mol. Formula | C34H41N7O5 |
| Mol. Weight | 627.7 |
| Synonyms | NA |
| Chemical Name | Ethyl (E)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In Stock |
Dabigatran is an anticoagulant medication belonging to the class of direct thrombin inhibitors. Structurally, it is a competitive and reversible inhibitor of thrombin, a key enzyme in the blood coagulation cascade. Administered orally, dabigatran is prescribed for the prevention of stroke and systemic embolism in individuals with atrial fibrillation. It is also used for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) following hip or knee replacement surgery. Dabigatran offers an alternative to traditional anticoagulants like warfarin and does not require frequent monitoring of coagulation parameters. Its targeted inhibition of thrombin plays a crucial role in preventing excessive blood clot formation. Buy high quality Dabigatran Etexilate from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Dabigatran Etexilate